Dear Friends,
Thought the following may be of some interest.
EBV-Specific CTLs Protect Against Lymphomas In Marrow Transplant
Recipients
WESTPORT, Feb 15 (Reuters Health) - Prophylactic infusions of
cytotoxic T cells specific for Epstein-Barr virus (EBV) appear to
provide protection against the development of EBV-associated
lymphomas in patients receiving allogeneic bone marrow
transplants, Swedish researchers report in the February 1st issue
of Blood.
http://ipn.intelihealth.com/ipn/ihtIPN?st=7189&c=268907
_
God Bless All,
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
